FDA Lifts Clinical Hold On Voyager For Huntington’s Gene Therapy Test

FierceBiotech (4/26, Adams) reports the FDA has lifted its clinical hold on Voyager Therapeutics’ “gene therapy candidate in Huntington’s disease (HD),” VY-HTT01, after the agency placed the hold “because of issues with chemistry, manufacturing and contro...